Xspray Pharma AB (publ)

Xspray Pharma AB (publ)verified

XSPRAY.ST

Price:

$31

Market Cap:

$1.14B

Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and HyNap-Dasa for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is based in Solna, Sweden.

Industry

Biotechnology

IPO Date

2017-09-28

Stock Exchange

STO

Ticker

XSPRAY.ST

The PE Ratio as of December 2025 (TTM) for Xspray Pharma AB (publ) (XSPRAY.ST) is -5.32

According to Xspray Pharma AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -5.32. This represents a change of -35.50% compared to the average of -8.25 of the last 4 quarters.

Xspray Pharma AB (publ) (XSPRAY.ST) Historical PE Ratio (quarterly & annually)

How has XSPRAY.ST PE Ratio performed in the past?

The mean historical PE Ratio of Xspray Pharma AB (publ) over the last ten years is -28.58. The current -5.32 PE Ratio has changed 1.76% with respect to the historical average. Over the past ten years (40 quarters), XSPRAY.ST's PE Ratio was at its highest in in the June 2017 quarter at 143.73. The PE Ratio was at its lowest in in the March 2018 quarter at -126.14.

Quarterly (TTM)
Annual

Average

-28.58

Median

-30.13

Minimum

-64.42

Maximum

-4.81

Xspray Pharma AB (publ) (XSPRAY.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Xspray Pharma AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 131.14%

Maximum Annual PE Ratio = -4.81

Minimum Annual Increase = -80.03%

Minimum Annual PE Ratio = -64.42

Quarterly (TTM)
Annual
YearPE RatioChange
2024-4.81-14.46%
2023-5.62-39.58%
2022-9.30-27.70%
2021-12.87-80.03%
2020-64.42131.14%
2019-27.87-31.19%
2018-40.504.17%
2017-38.88-20.91%
2016-49.1651.81%

Xspray Pharma AB (publ) (XSPRAY.ST) Average PE Ratio

How has XSPRAY.ST PE Ratio performed in the past?

The current PE Ratio of Xspray Pharma AB (publ) (XSPRAY.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.58

5-year avg

-19.40

10-year avg

-28.58

Xspray Pharma AB (publ) (XSPRAY.ST) PE Ratio vs. Peers

How is XSPRAY.ST’s PE Ratio compared to its peers?

Xspray Pharma AB (publ)’s PE Ratio is less than Cantargia AB (publ) (7.83), less than Orexo AB (publ) (-4.30), less than I-Tech AB (15.99), greater than Infant Bacterial Therapeutics AB (publ) (-8.45), greater than Senzime AB (publ) (-6.81), less than Oncopeptides AB (publ) (-4.35), less than Mendus AB (publ) (-2.43), greater than SynAct Pharma AB (-10.28), greater than Sedana Medical AB (publ) (-25.86), less than Ascelia Pharma AB (publ) (-3.94),

Build a custom stock screener for Xspray Pharma AB (publ) (XSPRAY.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xspray Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xspray Pharma AB (publ) (XSPRAY.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xspray Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Xspray Pharma AB (publ)'s PE Ratio?

How is the PE Ratio calculated for Xspray Pharma AB (publ) (XSPRAY.ST)?

What is the highest PE Ratio for Xspray Pharma AB (publ) (XSPRAY.ST)?

What is the 3-year average PE Ratio for Xspray Pharma AB (publ) (XSPRAY.ST)?

What is the 5-year average PE Ratio for Xspray Pharma AB (publ) (XSPRAY.ST)?

How does the current PE Ratio for Xspray Pharma AB (publ) (XSPRAY.ST) compare to its historical average?